Biodegradable hollow silica nanospheres containing gold nanoparticle arrays by Cassano, D. et al.
This is an Accepted Manuscript, which has been through the 
Royal Society of Chemistry peer review process and has been 
accepted for publication.
Accepted Manuscripts are published online shortly after 
acceptance, before technical editing, formatting and proof reading. 
Using this free service, authors can make their results available 
to the community, in citable form, before we publish the edited 
article. We will replace this Accepted Manuscript with the edited 
and formatted Advance Article as soon as it is available.
You can find more information about Accepted Manuscripts in the 
Information for Authors.
Please note that technical editing may introduce minor changes 
to the text and/or graphics, which may alter content. The journal’s 
standard Terms & Conditions and the Ethical guidelines still 
apply. In no event shall the Royal Society of Chemistry be held 
responsible for any errors or omissions in this Accepted Manuscript 





Journal Name RSCPublishing 
COMMUNICATION 
This journal is © The Royal Society of Chemistry 2012 J. Name., 2012, 00, 1-3 | 1  
Cite this: DOI: 10.1039/x0xx00000x 
Received 00th January 2012, 
Accepted 00th January 2012 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
Biodegradable Hollow Silica Nanospheres Containing 
Gold Nanoparticle Arrays  
Domenico Cassano,
a,b














We introduce biodegradable hollow silica nanocapsules 
embedding arrays of 3 nm gold nanoparticles. The silica shell 
degrades in full serum in few hours, potentially allowing the 
clearance of the capsules and their contents by the efficient 
renal pathway, and therefore overcoming accumulation issues 
typical of metal nanoparticles. 
The huge promise of the application of engineered nanoparticles for 
theranostics stems from the possibility to design their geometry and 
surface coating to achieve peculiar chemical, physical and 
physiological features, allowing simultaneous targeting, diagnostic, 
and/or therapeutic functionality, potentially tailored for a specific 
patient or disease.1,2 Notably, the average diameter of most of the 
metal inorganic nanoparticles – which shown an enormous potential 
for the therapy and/or diagnosis of a number of cancers3 –  proposed 
for in vivo theranostics is over 20 nm.1,4,5 Unluckily, excretion of 
objects above 10 nm occurs through liver and spleen into bile and 
feces but the excretion of intact metal nanoparticles from these 
pathways is an extremely slow and inefficient process, leading to 
unwanted accumulation which in turns causes increased toxicity and 
interference with common medical diagnosis.6,7 US Food and Drug 
Administration requires that agents injected into the human body, 
especially diagnostic agents, are cleared completely in a reasonable 
amount of time, avoiding persistence in the organism;6 this requisite is 
currently not fulfilled by any metal based nanoparticle.4  
On the other hand, nanoparticles with a diameter of few nanometers 
would show ideally-fast clearance kinetics through renal excretion, 
which is controlled by glomerular filtration and shows a threshold of 
maximum 6 nm,1,6,8,9 though it should be noted that excessively fast 
clearance could hamper some therapeutic applications.1,10 Yet, the 
physical and chemical properties of metallic nanoparticles strongly 
depend on their size and the promise shown by particles above 20 nm 
size range are usually lost or altered when they are made smaller.11 
Overall, the dilemma concerning the optimal particle size for clinical 
applications is still unresolved,1 and only few suggestions were 
proposed that partially address the issue.10,12  
Here, we present a modular system that combines the optical 
behavior of metal nanoparticles with a potentially complete body 
clearance. Our proposed structure is composed of three elements: 1) 
small gold nanoparticles (diameter: 3 nm), 2) commercial polymers 
surrounding the gold nanoparticles; 3) a degradable silica shell 
embedding the polymer-nanoparticle assembly. Interestingly, the 
degradation products of these nanomaterials are the polymers, small 
gold nanoparticles and silicic acid,13 compatible with the possibility to 
overcome accumulation owing to the renal clearance of these building 
blocks. 
The general synthetic approach employed for the preparation of 
hollow silica nanospheres containing the gold nanoparticles array 
(AuSi) is shown in Figure 1A. Gold nanoparticles of 2.8±0.4 nm (Figure 
1B) coated by negative poly(sodium 4-styrene sulfonate) (PSS) were 
aggregated in spherical arrays by the positive poly(D- or L-lysine) (PL) 
by means of ionic interactions, and then the silica shell was grown on 
this template by a modified Stöber method.13 We suggest that the 
hollow silica nanosphere formation around the gold array is linked to 
the presence in the same gold aggregate of both amines from PL and 
aromatic moieties from PSS. Indeed it was demonstrated that PL 
alone can be used as template by resulting in hollow silica 
microsphere only in presence of aromatic additives.14  


















COMMUNICATION Journal Name 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
Figure 1. A) Top panel: scheme for the general formation of the nanosystem. 
Negative gold nanoparticles are assembled in spherical arrays employing poly(L-
lysine) or dye-modified poly(L-lysine). These cores are then embedded in hollow 
silica shells. After calcination the organic compounds are burned and the silica 
shell remained intact, while gold nanoparticles are melted in a single bigger gold 
nanoparticle presenting a “naked” surface. Bottom panel: TEM images of each 
synthetic step. Scalebars 25 nm. B) Size distribution histograms of gold 
nanoparticles. C) Size distribution histograms of AuSi made by employing poly(L-
lysine) of various molecular weight: AuSi1 (1-5 kDa) in turquoise, AuSi2 (4-15 
kDa) in blue, AuSi3 (15-30 kDa) in red and AuSi4 (70-150 kDa) in black. All the 
histograms were made on diameter measurements of at least 100 nanoparticles 
observed by TEM. 
For consistence of the work, all the reported results are related to 
AuSi systems synthesized using poly(L-lysine). TEM images at 
different tilted angles (Supporting Information Figure S1) and SEM 
images (Supporting Information Figure S2) confirmed the presence of 
gold nanoparticles only inside the cavity of silica nanospheres and not 
entrapped in the wall or on the external surface of the structures.  
The hollow silica nanospheres are formed around the gold arrays, 
which are used as templates. Thus, a good control over the size of 
gold aggregates is required in order to obtain AuSi with a size in the 
nanometer range.14 This was achieved by employing during the array 
formation an optimized weight ratio between gold nanoparticles and 
PL (see Supporting Information), which decreases the possibility to 
have large aggregates (Supporting Information Figure S3). Also, in 
order to test if the size of AuSi was related to the molecular weight of 
the PL used for the array formation (Figure 1C), various PLs were 
employed: PL 1-5 kDa was used to synthesize AuSi1 systems, while PL 
4-15 kDa for AuSi2, PL 15-30 kDa for AuSi3 and PL 70-150 kDa for 
AuSi4, yielding nanosystems with diameters of: 59±8 nm, 93±11 nm, 
108±12 nm, and 110±13 nm respectively. Apparently, there is no strict 
relation between diameters of AuSi1-4 and polymerization degree of 
PLs.14 This trend can be probably ascribed to the purification protocol 
employed, in which the colloids are subjected to a short centrifugation 
step after the reactions in order to remove the larger particles (see 
Supporting Information).  
Keeping in mind that physiological effects such as the Enhanced 
Permeability and Retention (EPR) are optimally addressed as a viable  
Figure 2. A) Spectral behavior of 3 nm gold nanoparticles (blue), gold arrays 
(green), AuSi3 (purple), and calcinated AuSi3 (black). Spectra were collected in 
milliQ water, normalized and the background subtracted. B) Absorbance (left) 
and SERS (right, background subtracted) spectra of AuSi3A collected, 
respectively, in ethanol and milliQ water. 
theranostics pathway by particles sized around 100 nm,1 we focused 
on the synthesis of AuSi3. The optical behavior of the latter and of its 
components is reported in Figure 2A. The extinction band of the  
mother solution of gold nanostructures is below 520 nm. As expected, 
the band shifts to red (at 539 nm) after the aggregation with PL, 
owing to the close proximity of the nanoparticles in the array. When 
gold arrays are included in the hollow silica nanospheres the 
extinction band experiences a minor blue-shift to 532 nm, likely due to 
increased purity and more homogeneous size of the processed 
nanostructures (see Supporting Information). This  demonstrates that 
gold nanoparticles in AuSi3 are actually kept strictly packed in a 
spherical shape by PL, showing optical behavior that could promote 
typical diagnostic/therapeutic applications of metal nanoparticles.15,16 
Notably, we observed that upon calcination, the polymers in the AuSi 
cavity are degraded and gold nanoparticles melt forming a single gold 
structure (see Supporting Information Figures S4-5) whose optical 
behavior is similar to AuSi3. 
An interesting aspect of AuSi nanocapsules stems from the possibility 
of incorporating other functional motifs inside their core, such as 
drugs or magnetic elements for the production of multimodal 
systems. To test this feature, PL 15-30 kDa was modified with 
AlexaFluor-680 NHS ester and used to synthesize the gold arrays and 
then the AuSi3A system. The absorbance spectrum of AuSi3A is 
reported in Figure 2B (left panel), where both bands of gold array and 
of the dye are present. SERS experiments were performed (Figure 2B  
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Figure 3. A) SEM images of AuSi3 after incubation in full serum at 37 ˚C. 
Scalebars: 200 nm. 
right panel) in order to confirm the presence of the fluorophore in the 
cavity of AuSi3A and near the gold nanoparticles surface. The SERS 
signals were compared and consistent with the Raman shifts achieved 
from milliQ water solution of AlexaFluor-680 (Supporting Information 
Figure S6) demonstrating that the modification of PL does not affect 
its solvating properties over gold nanoparticles and thus the success 
of the reaction. It is also noticeable that: i) the surface of these highly 
reproducible systems is modifiable by functional coatings with 
standard protocols (Supporting Information Figure S7), and ii) they 
can be subjected to freeze-drying and stored for up to one year 
without losing their properties.  
We also evaluated degradation kinetics of our nanostructures in 
physiological media, comparing our results with similar findings 
obtained with silica nanoparticles.13 We performed SEM imaging 
experiments of AuSi3 incubated in full serum at 37 ˚C (Figure 3). After 
six hours the nanosystems lose their spherical shape appearing 
eroded, while after 18 hours no more nanoparticles were observed in 
the samples. Note that the maximum silicic acid solubility can exceed 
the equilibrium saturation concentration (see Supporting Information) 
causing a condensation via Ostwald ripening effect and forming the 
background material on the silicon wafer.13  
Overall, it can be envisioned that the proposed nanosystem: i) reaches 
the target in the organism, ii) exploits its therapeutic/diagnostic 
action, iii) biodegrades in the building blocks and the latter are 
excreted. It is also reasonable to expect that the released gold 
nanoparticles be completely coated by endogenous glutathione 
before the renal clearance, decreasing their possible adverse effect.17  
Conclusions 
In summary we have presented a highly reproducible, functional and 
biodegradable nanosystem composed by hollow silica nanoparticles 
in which 3 nm gold nanoparticles are embedded in their central cavity 
in a narrow array, able to simulate the optical behaviour of a single 
larger gold nanoparticle. Noticeably, these nanosystems stand as 
promising tools to overcome the issue of accumulation of inorganic 
nanoparticles in organisms. Preliminary in vivo photoacoustic and x-
ray experiments are ongoing. Also, the possibilities to develop gold 
arrays with peculiar geometries (and thus peculiar optical behaviour, 
such as rods) and nanosystems devoid of metal nanoparticles are 
under investigation. Finally, their calcination produces “naked” gold 
nanoparticles – i.e. without any type of coating on the surface - 
shielded by the hollow permeable silica nanospheres. These 
nanosystems could be very performing as catalysers over a number of 
reactions, among which the water-gas shift reaction. This task will be 
also supported by the versatility of the nanosystems, i.e. the 
possibility to synthesize nanostructures composed by various metals, 
among which platinum and silver. 
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